Inflammatory cytokines and venous thrombosis bidirectional causal correlations: A Mendelian randomization study

炎症细胞因子与静脉血栓形成双向因果关系:一项孟德尔随机化研究

阅读:2

Abstract

Previous studies have demonstrated that venous thromboembolism (VTE) is characterized by the interplay between inflammatory mechanisms and coagulation cascades. However, these observational studies may be susceptible to biases such as reverse causation and unmeasured confounding, leaving the causal relationship between inflammation and VTE unclear. To better understand this relationship, we conducted a 2-sample Mendelian randomization (MR) study, employing a bidirectional MR analysis using publicly available genome-wide association statistics. To enhance the reliability of our findings, we utilized 5 distinct approaches (inverse variance weighted, MR-Egger, weighted median, simple mode, and weighted mode) for MR analysis and performed rigorous tests for heterogeneity and horizontal pleiotropy. The study included 4185 individuals diagnosed with pulmonary embolism (PE) and 4576 cases of deep vein thrombosis (DVT). The forward MR analysis indicated a positive correlation between elevated levels of granulocyte colony stimulating factor (odds ratio [OR]: 1.36, P = 6.15 × 10-4) and interleukin-2 (OR: 1.17, P = .023) with an increased susceptibility to PE. Additionally, Eotaxin (OR: 1.18, P = 5.92 × 10-3) was positively correlated with an elevated risk of DVT. Conversely, the reverse MR analysis revealed no discernible causal link between PE, DVT, and 41 inflammatory cytokines. Our study concludes that granulocyte colony stimulating factor and interleukin-2 are risk factors for PE, while Eotaxin is a risk factor for DVT. Furthermore, reverse analyses confirmed that neither PE nor DVT serve as risk factors for elevated levels of the 41 inflammatory cytokines. Our research furnishes novel evidence underpinning a causal relationship between inflammatory cytokines and VTE. This newfound knowledge may offer invaluable insights for the development of early - screening methods and intervention therapies for VTE in the future.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。